In an era of increasingly bespoke healthcare, Elizabeth Philp has emerged as a significant voice of innovation, particularly in the tech-driven field of compounded pharmacy. As the co-founder and CEO of Roseway Labs, Philp is at the forefront of a push to make bespoke medications more obtainable, questioning the standard one-size-fits-all approach